Radiofrequency Ablation Duration per Tumor Volume May Correlate with Overall Survival in Solitary Hepatocellular Carcinoma Patients Treated with Radiofrequency Ablation Plus Lyso-Thermosensitive Liposomal Doxorubicin
Publication
, Journal Article
Celik, H; Wakim, P; Pritchard, WF; Castro, M; Leonard, S; Karanian, JW; Dewhirst, MW; Lencioni, R; Wood, BJ
Published in: JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
December 1, 2019
Duke Scholars
Published In
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
DOI
EISSN
1535-7732
ISSN
1051-0443
Publication Date
December 1, 2019
Volume
30
Issue
12
Start / End Page
1908 / 1914
Publisher
ELSEVIER SCIENCE INC
Related Subject Headings
- Nuclear Medicine & Medical Imaging
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Celik, H., Wakim, P., Pritchard, W. F., Castro, M., Leonard, S., Karanian, J. W., … Wood, B. J. (2019). Radiofrequency Ablation Duration per Tumor Volume May Correlate with Overall Survival in Solitary Hepatocellular Carcinoma Patients Treated with Radiofrequency Ablation Plus Lyso-Thermosensitive Liposomal Doxorubicin. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 30(12), 1908–1914. https://doi.org/10.1016/i.jvir.2019.04.023
Celik, Haydar, Paul Wakim, William F. Pritchard, Meryll Castro, Shelby Leonard, John W. Karanian, Mark W. Dewhirst, Riccardo Lencioni, and Bradford J. Wood. “Radiofrequency Ablation Duration per Tumor Volume May Correlate with Overall Survival in Solitary Hepatocellular Carcinoma Patients Treated with Radiofrequency Ablation Plus Lyso-Thermosensitive Liposomal Doxorubicin.” JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY 30, no. 12 (December 1, 2019): 1908–14. https://doi.org/10.1016/i.jvir.2019.04.023.
Celik H, Wakim P, Pritchard WF, Castro M, Leonard S, Karanian JW, et al. Radiofrequency Ablation Duration per Tumor Volume May Correlate with Overall Survival in Solitary Hepatocellular Carcinoma Patients Treated with Radiofrequency Ablation Plus Lyso-Thermosensitive Liposomal Doxorubicin. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. 2019 Dec 1;30(12):1908–14.
Celik, Haydar, et al. “Radiofrequency Ablation Duration per Tumor Volume May Correlate with Overall Survival in Solitary Hepatocellular Carcinoma Patients Treated with Radiofrequency Ablation Plus Lyso-Thermosensitive Liposomal Doxorubicin.” JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, vol. 30, no. 12, ELSEVIER SCIENCE INC, Dec. 2019, pp. 1908–14. Wos, doi:10.1016/i.jvir.2019.04.023.
Celik H, Wakim P, Pritchard WF, Castro M, Leonard S, Karanian JW, Dewhirst MW, Lencioni R, Wood BJ. Radiofrequency Ablation Duration per Tumor Volume May Correlate with Overall Survival in Solitary Hepatocellular Carcinoma Patients Treated with Radiofrequency Ablation Plus Lyso-Thermosensitive Liposomal Doxorubicin. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. ELSEVIER SCIENCE INC; 2019 Dec 1;30(12):1908–1914.
Published In
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
DOI
EISSN
1535-7732
ISSN
1051-0443
Publication Date
December 1, 2019
Volume
30
Issue
12
Start / End Page
1908 / 1914
Publisher
ELSEVIER SCIENCE INC
Related Subject Headings
- Nuclear Medicine & Medical Imaging
- 3202 Clinical sciences
- 1103 Clinical Sciences